Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes-Reference-Cited by-同舟云学术

Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes

Published:2013-09-10 Issue:23 Volume:119 Page:4094-4102
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Okuwaki Kosuke¹,Kida Mitsuhiro¹,Mikami Tetuo²,Yamauchi Hiroshi¹,Imaizumi Hiroshi¹,Miyazawa Shiro¹,Iwai Tomohisa¹,Takezawa Miyoko¹,Saegusa Makoto²,Watanabe Masahiko³,Koizumi Wasaburo¹

Affiliation:

1. Department of Gastroenterology; Kitasato University East Hospital; Kanagawa Japan

2. Department of Pathology; Kitasato University East Hospital; Kanagawa Japan

3. Department of Surgery; Kitasato University East Hospital; Kanagawa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28341/fullpdf

Reference22 articles.

1. Expression of somatostatin receptor (SSTR) subtypes (SSTR-1, 2A, 3, 4 and 5) in neuroendocrine tumors using real-time RT-PCR method and immunohistochemistry;Mizutani;Acta Histochem Cytochem.,2012

2. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors;Ducreux;Am J Gastroenterol.,2000

3. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by Italian Trials in Medical Oncology Group;Bartolomeo;Cancer.,1996

4. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile;Bruns;Eur J Endocrinol.,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms;Cancers;2024-05-08

2. Surgical resection of double advanced pancreatic neuroendocrine tumors with multiple renal cell carcinoma associated with von Hippel–Lindau disease;Clinical Journal of Gastroenterology;2024-05-02

3. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors;Scientific Reports;2024-02-19

4. Molecular alterations and therapeutic targets in pancreatic neuroendocrine tumors;Journal of Pancreatology;2023-03-24

5. Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms;Cancers;2023-03-20